Aspen Aerogels, Inc. $ASPN Shares Sold by Penbrook Management LLC

Penbrook Management LLC lessened its holdings in shares of Aspen Aerogels, Inc. (NYSE:ASPN) by 21.9% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 14,180 shares of the construction company’s stock after selling 3,975 shares during the period. Penbrook Management LLC’s holdings in Aspen Aerogels were worth $84,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Gagnon Securities LLC acquired a new stake in shares of Aspen Aerogels during the 2nd quarter worth about $11,243,000. Gagnon Advisors LLC acquired a new stake in shares of Aspen Aerogels during the 2nd quarter worth about $3,348,000. Perigon Wealth Management LLC raised its position in shares of Aspen Aerogels by 12.7% during the 2nd quarter. Perigon Wealth Management LLC now owns 37,866 shares of the construction company’s stock worth $224,000 after acquiring an additional 4,270 shares in the last quarter. Goldman Sachs Group Inc. increased its position in Aspen Aerogels by 89.7% during the first quarter. Goldman Sachs Group Inc. now owns 1,274,356 shares of the construction company’s stock worth $8,143,000 after buying an additional 602,586 shares during the period. Finally, Acadian Asset Management LLC acquired a new position in Aspen Aerogels during the first quarter worth approximately $43,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

Aspen Aerogels Trading Up 6.1%

NYSE:ASPN opened at $8.46 on Tuesday. The firm has a market cap of $696.35 million, a P/E ratio of -2.22 and a beta of 2.80. The company has a current ratio of 3.98, a quick ratio of 3.31 and a debt-to-equity ratio of 0.34. The stock’s 50 day simple moving average is $7.16 and its 200-day simple moving average is $6.49. Aspen Aerogels, Inc. has a 12-month low of $4.16 and a 12-month high of $26.90.

Aspen Aerogels (NYSE:ASPN) last released its earnings results on Thursday, August 7th. The construction company reported ($0.04) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.12) by $0.08. The business had revenue of $78.02 million for the quarter, compared to analyst estimates of $72.53 million. Aspen Aerogels had a positive return on equity of 2.92% and a negative net margin of 78.53%.The company’s revenue for the quarter was down 33.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.21 earnings per share. Aspen Aerogels has set its FY 2025 guidance at -3.860–3.730 EPS. Equities analysts anticipate that Aspen Aerogels, Inc. will post 0.17 EPS for the current year.

Insider Activity

In other news, CAO Santhosh P. Daniel sold 4,410 shares of the business’s stock in a transaction that occurred on Tuesday, August 12th. The stock was sold at an average price of $7.31, for a total value of $32,237.10. Following the transaction, the chief accounting officer owned 19,879 shares of the company’s stock, valued at approximately $145,315.49. The trade was a 18.16% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 3.40% of the company’s stock.

Analysts Set New Price Targets

Several research firms have commented on ASPN. Barclays lowered Aspen Aerogels from an “equal weight” rating to an “underweight” rating and lifted their price target for the stock from $7.00 to $16.00 in a research report on Monday, August 11th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Aspen Aerogels in a research report on Wednesday, October 8th. Finally, Canaccord Genuity Group cut their price target on Aspen Aerogels from $11.00 to $10.00 and set a “buy” rating on the stock in a research report on Friday, August 8th. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, two have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $19.50.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.